AbbVie Science Chief to Retire With No Successor in Place

AbbVie Inc.’s long-time head of research will retire from the drugmaker, leaving the newly spun off company without a leader for its efforts to develop new medicines and buttress its future prospects.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.